Navigation Links
Lowering Contrast Material Injection in Aged Patients is Cost-effective and can Offset Risks

A new study has found that it is better to alter the dosage of senior patients undergoing multi-detector CT examination of the pancreas //and biliary region, by bringing it down by 10%. This would lower the cost of the examination as well as the risk of complications. This study was conducted by the Department of Technical Radiology at Nagoya University School of Health Science in Nagoya, Japan.

"When interpreting CT images acquired using the established protocol in our clinical practice, it was noted that in some examinations of elderly patients, contrast enhancement of the pancreatic parenchyma was too intense," said Shigeki Itoh, MD, lead author of the study. "Therefore, we speculated that it might be possible to reduce the dose and rate of contrast material injection without adversely affecting the degree of contrast enhancement in elderly patients," said Dr. Itoh.

The study included 112 patients, ranging from 23-80 years old who had known or suspected pancreatobiliary disease who were split into three groups (60 years old or younger with a contrast injection of 0.08 milliliters/kg/sec, 60 years old or older with a contrast injection of 0.08 milliliters/kg/sec, and 60 years old or older with a contrast injection of 0.07 milliliters/kg/sec).

Group 3 had a 12.2% reduction in the volume and rate of contrast material injection. According to previous studies, contrast enhancement in the vessels and the organs of the abdomen increases with an increase in the volume and rate of contrast material injection. However, Dr. Itoh said that this wasn't the case in his study. Dr. Itoh noted it is essential to administer contrast material only at the volume and rate needed to achieve an adequate level of contrast enhancement for diagnosis.


Page: 1

Related medicine news :

1. Lowering blood pressure beneficial for PAD patients
2. Lowering Risk of Breast Cancer Recurrence
3. Multi-Drug Therapy Effective in Lowering Blood Pressure
4. Multi-Drug Therapy Found To Be More Effective in Lowering B.P
5. Almonds found To Be Effective In Lowering Cholesterol
6. Almonds As Effective As Certain Drugs In Lowering Cholesterol
7. Using Cholesterol Lowering Drugs Effectively
8. Lowering cholesterol with vegetables in your diet
9. Fibre Rich Food A Boon For Lowering Cholesterol
10. Dark Chocolate Is Helpful In Lowering Blood Pressure.
11. Plant – based Foods More Effective In Lowering Cholesterol
Post Your Comments:

(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... National recruitment ... a life sciences executive with extensive sequencing and genomics experience, as Vice President of ... position, Ms. Hill will be responsible for leading the sales team in the commercialization ...
(Date:6/24/2016)... Gaithersburg, MD (PRWEB) , ... June 24, 2016 ... ... and protocols for human induced pluripotent stem (iPS) cells and other difficult to ... PluriQ™ G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: